Chunrong Li

china west normal university

H指数:20

被引数:1,444

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Construction of S-scheme ZnWO4/ZnS heterojunction with enhanced charge separation for efficient photocatalytic hydrogen evolution

构建具有增强电荷分离的S型ZnWO4/ZnS异质结，用于高效光催化氢气 evolution

Journal of Alloys and Compounds

IF6.3

2025-11-240

PRE

Fabrication of S-scheme NiFe-LDH/Zn2In2S5 heterojunction for boosting photocatalytic hydrogen evolution

S-型NiFe-LDH/Zn2In2S5异质结的制备及其光催化氢气生成性能提升

Journal of Environmental Chemical Engineering

IF7.2

2025-10-260

PRE

Development of Potent and Selective RIPK1 Degraders Targeting Its Nonenzymatic Function for Cancer Treatment

开发靶向RIPK1非酶功能用于癌症治疗的强效且高选择性RIPK1降解剂

Journal of Medicinal Chemistry

IF6.8

2025-07-160

PRE

Development of folate receptor targeting chimeras for cancer selective degradation of extracellular proteins

NATURE COMMUNICATIONS

IF15.7

2024-10-081

OAAI

A platform for the rapid synthesis of molecular glues (Rapid-Glue) under miniaturized conditions for direct biological screening

在用于直接生物筛选的小型化条件下快速合成分子胶 (rapid-Glue) 的平台

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-10-0113

OAAI

Development and Characterization of Third Generation MDM2 PROTACs for the Treatment of Acute Myeloid Leukemia Utilizing an Achiral Ligand for E3 Ligase Cereblon

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2023-06-010

OAAI

Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-02-0723

PRE

A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-06-0137

OAAI

Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes

Nf-κb阻断剂BAY11-7082通过降低NLRP3炎性小体抑制C57BL/6J小鼠实验性自身免疫性脑脊髓炎的潜在作用

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2021-11-2723

EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice

PLOS PATHOGENS

IF4.9

2020-06-1524

OAAI

Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-11-024

OAAI

Co-targeting of Axl and MerTK improves radiation response in HNSCC

CANCER RESEARCH

IF16.6

2018-07-011

PRE

Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer murine xenograft models

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Combining the pan-FGFR inhibitor AZD4547 with radiation in lung and head and neck squamous cell carcinoma

CANCER RESEARCH

IF16.6

2017-07-011

PRE

Simultaneous targeting of EGFR and ALK in EML4-ALK positive lung cancer to inhibit tumor cell proliferation and migration

CANCER RESEARCH

IF16.6

2016-07-151

PRE

Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers

MOLECULAR CANCER THERAPEUTICS

IF5.5

2015-09-0228

OAAI

Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors

MOLECULAR CANCER THERAPEUTICS

IF5.5

2015-09-0243

OAAI

Co-inhibition of ALK and EGFR and/or c-MET on cell growth and response to radiation in ALK-positive NSCLC cells

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab

CANCER BIOLOGY & THERAPY

IF4.6

2014-10-2812

OAAI

Combination of crizotinib and radiation in the treatment of ALK-positive and cetuximab-resistant lung cancer

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Chunrong Li

个人简介

教育背景

工作经历

荣誉奖项

研究方向